iftelse. Amplification of MYCN is a genetic abnormality found in approximately one third of all human neuroblastomas and 
closely associated with advanced stage and poor outcome. A murine 20685848 model of neuroblastoma has been established by targeted expression of the human MYCN oncogene in neuroectodermal cells under the control of rat tyrosine hydroxylase promoter . Use of transgenic mice expressing the human MYCN oncogene has provided definitive evidence for the role of MYCN in neuroblastoma tumorigenesis, recapitulating several biological and histological aspects of clinical neuroblastomas. There are circumstances where both hemizygous and homozygous transgenic mice are necessary to explore the role of MYCN in neuroblastomas. So far, homozygous transgenic mice have been identified by either Southern blot or quantitative real-time PCR. Quantitative real-time PCR is dependent on the quantification of differential amounts of transgene DNA between hemizygous and homozygous transgenic mice, thus, all procedures should be carried out meticulously with particular attention to the quality of DNA preparation. Additionally, reliable results of genotyping may take several days to obtain. Inverse PCR has numerous applications in molecular biology including amplification and identification of genomic inserts. IPCR is generally used if only one internal sequence of the target DNA is known. It is therefore especially useful in identifying flanking DNA sequences of genomic inserts. If one or more of the TH-MYCN transgene/host DNA junctions have been sequenced, it is convenient to design a PCR to distinguish homozygotes from hemizygotes. With the aim of facilitating genotype analysis of TH-MYCN transgenic mice, we analyzed the arrangement of integrated DNA in transgenic mice by Southern blot and inverse IPCR analyses. In this study, we were successful to Trametinib manufacturer identify the transgene locus, in which head-to-tail tandem repeats were integrated at a single insertion site at chromosome locus 18qE4. Using primers flanking the integrated TH-MYCN transgene, rapid and reliable genotyping was achieved by conventional PCR. Materials and Methods Mice 129X1/SvJ strain of TH-MYCN transgenic mice were backcrossed with 129+Ter/SvJ strain in our animal Genotyping for MYCN Tg Mice facility. In this study, both substrains were examined. All of the mice were maintained and used in accordance with guidelines issued by the Institutional Animal Care and Use Committee. Genomic DNA preparation For genotyping PCR analysis, 12 mm sections of tail tip were dissolved in 0.1 ml of 50 mM Tris, 100 mM EDTA, 0.5% SDS, and 0.5 mg/ml proteinase K solution at 55uC for at least one hour with vigorous shaking. The DNA was purified by phenol/chloroform extraction followed by ethanol precipitation and then dissolved in 0.5 ml of TE solution. For Southern blot and inverse PCR analyses, genomic DNA was prepared from digested 24678947 liver using DNA Isolation Kit for Cells and Tissues. and alkaline transferred to a positively charged nylon membrane. DIG-labeled DNA probes were used for Southern blot analysis and all procedures for the DIG application system were performed according to the manufacturer’s recommendations. Inverse PCR Genomic DNA digested with PstI restriction enzyme was separated by agarose gel electrophoresis with molecular weight marker and the region corresponding to 1.4 kb was cut out. DNA was eluted using QIAquick Gel Extraction Kit and selfligated with T4 DNA ligase at 16uC over night. After
